Rapid Micro Biosystems (RPID) Revenue (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Revenue data on file, last reported at $8.0 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 11.06% year-over-year to $8.0 million; the trailing twelve-month figure through Mar 2026 stood at $34.4 million (up 15.99% YoY), and the FY2025 full-year result was $33.6 million, up 19.74% from the prior year.
• Revenue retreated to $8.0 million in Q1 2026, from $11.3 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $11.3 million in Q4 2025 to a low of $3.9 million in Q2 2022.
• A 5-year average of $6.4 million and a median of $6.3 million in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue tumbled 37.03% in 2022 and surged 44.88% in 2023, its largest moves.
• Tracing RPID's Revenue over 5 years: stood at $4.4 million in 2022, then jumped by 44.88% to $6.3 million in 2023, then climbed by 29.68% to $8.2 million in 2024, then jumped by 37.28% to $11.3 million in 2025, then decreased by 29.07% to $8.0 million in 2026.
• Business Quant data shows RPID's Revenue at $8.0 million in Q1 2026, $11.3 million in Q4 2025, and $7.8 million in Q3 2025.